扣非连亏股易瑞生物控股股东拟减持 上月公告套现亿元

Core Viewpoint - The announcement from Yirui Biotechnology (300942.SZ) reveals plans for share reduction by its controlling shareholder and associated parties, indicating a potential liquidity event without significant impact on the company's governance or control structure [1][2]. Share Reduction Plan - Yirui (Hainan) Venture Capital Co., Ltd. plans to reduce its holdings by up to 11,521,758 shares, representing 2.84% of the total share capital, while associated entities plan to reduce their holdings by 288,500 shares (0.07%) and 341,800 shares (0.08%) respectively, totaling a maximum reduction of 12,152,058 shares or 3% of the total [1][2]. - The estimated cash proceeds from the planned share reduction amount to approximately 127.6 million yuan based on the last closing price of 10.50 yuan per share [1]. Current Shareholding Structure - As of the announcement date, Yirui Venture Capital holds 132,369,971 shares (32.68%), Yida Rui holds 19,008,003 shares (4.69%), and Yikai Rui holds 22,577,203 shares (5.57%) [2]. Previous Share Reduction Activities - Recent share reductions included Yirui Venture Capital selling 3,531,208 shares at an average price of 10.66 yuan per share, and the actual controller Zhu Hai reducing his holdings through various transactions, totaling approximately 125 million yuan from July to September 2025 [3]. Fundraising and Financial Performance - Yirui Biotechnology raised a total of 5.45 billion yuan from two fundraising events, with net profits for the years 2021 to 2024 showing fluctuations, including a loss of approximately 184.9 million yuan in 2023 [4][6].